Literature DB >> 20096462

Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.

Karen Dunlap1, Garrick Chak, James V Aquavella, Elliott Myrowitz, Canan Asli Utine, Esen Akpek.   

Abstract

PURPOSE: To report the short-term visual outcomes after keratoprosthesis implantation.
DESIGN: Retrospective multi center case series (Wilmer Eye Institute and University of Rochester Eye Institute). PARTICIPANTS: One hundred twenty-two patients (126 eyes) with corneal diseases that were deemed ineligible to receive donor corneal transplants. INTERVENTION: Patients underwent a Boston type I keratoprosthesis procedure for visual rehabilitation. MAIN OUTCOME MEASURES: The medical records of the patients were reviewed to assess intraoperative and postoperative complications, uncorrected and best-corrected visual acuity, as well as the degree of refractive error at various time points.
RESULTS: One hundred four patients (82.5%) achieved improved vision within 6 months after surgery. An overwhelming majority of those patients who had improved vision had a manifest refraction of plano. The mean spherical refractive error was -0.57 diopters (D) and mean astigmatism was 0.10 D. Cumulatively, 7.1% patients achieved their best-corrected vision at 1 day, 24.6% at 1 week, and 70.6% at 3 months. The patients who achieved their best-corrected visual acuity after the first 3-month period most often were the ones who required multiple surgeries owing to preexisting or postoperative complications.
CONCLUSIONS: Boston keratoprosthesis seems to provide rapid visual recovery with excellent uncorrected acuity in the early postoperative period. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any of the materials discussed in this article. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20096462     DOI: 10.1016/j.ophtha.2009.09.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Evaluation of immersion 20 MHz B-scan ultrasonography in observing lens in the alkali burn eyes.

Authors:  Qing-Hua Yang; Bing Chen; Li-Qiang Wang; Guang-Hua Peng; Zhao-Hui Li; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

3.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Masako Chen; Sueko M Ng; Esen K Akpek; Sumayya Ahmad
Journal:  Cochrane Database Syst Rev       Date:  2020-05-13

Review 4.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Esen K Akpek; Majed Alkharashi; Frank S Hwang; Sueko M Ng; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2014-11-05

5.  Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO.

Authors:  Jose L Güell; Edilio Arcos; Oscar Gris; Diego Aristizabal; Miguel Pacheco; Claudia L Sanchez; Felicidad Manero
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

6.  Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.

Authors:  Maria Stephanie R Jardeleza; Marc-Andre Rheaume; James Chodosh; Anne Marie Lane; Claes H Dohlman
Journal:  Digit J Ophthalmol       Date:  2015-12-21

7.  Keratoprosthesis in congenital hereditary endothelial dystrophy after multiple failed grafts.

Authors:  Ramez I Haddadin; Claes H Dohlman
Journal:  Digit J Ophthalmol       Date:  2011-09-23

8.  Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).

Authors:  Esen K Akpek; Sandra D Cassard; Karen Dunlap; Sarah Hahn; Pradeep Y Ramulu
Journal:  Trans Am Ophthalmol Soc       Date:  2015

9.  A novel murine model for keratoprosthesis.

Authors:  Alja Crnej; Masahiro Omoto; Thomas H Dohlman; John M Graney; Claes H Dohlman; Brigita Drnovsek-Olup; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-15       Impact factor: 4.799

10.  Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization.

Authors:  Lee Kiang; Mark I Rosenblatt; Rachel Sartaj; Ana G Alzaga Fernandez; Szilard Kiss; Nathan M Radcliffe; Donald J D'Amico; Kimberly C Sippel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.